VJRegenMed is committed to improving our service to you

Share this video  

VJRegenMed is committed to improving our service to you

Advanced Therapies 2020 | LUMEVOQ: gene therapy for Leber hereditary optic neuropathy

Magali Taiel • 1 Sep 2020
Advanced Therapies 2020
Leber Hereditary Optic Neuropathy Rare Diseases
Treatment

Magali Taiel, MD, of GenSight Biologics, Paris, France, discusses LUMEVOQ gene therapy for patients with Leber hereditary optic neuropathy, a mitochondrial inherited form of vision loss. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

More from Magali Taiel

4:19
RESCUE & REVERSE: long-term follow ups of LUMEVOQ gene therapy
Magali Taiel • 1 Sep 2020
2:40
LUMEVOQ gene therapy for LHON
Magali Taiel • 6 Oct 2021

Related Videos

1:38
Overcoming manufacturing issues in gene therapies for rare diseases
John Maslowski • 27 Jan 2022
2:12
Innovations in treating rare diseases with gene therapies
John Maslowski • 27 Jan 2022
1:57
Tailored nucleases for primary hyperoxaluria
Devyn Smith • 29 Oct 2021
2:38
Expanding the repertoire of CRISPR-based genomic editors
Devyn Smith • 29 Oct 2021
The content of VJRegenMed is intended for healthcare professionals